Breast cancer costs low-income women more jobs Poor women undergoing breast cancer treatment are four times more likely to lose their jobs than their high-income peers, a new study suggests.
Colorectal cancer rates rise sharply in younger US adults Colorectal cancer rates are on the rise among millennials and Gen Xers in the U.S., a new study finds.
Lawyer diagnosed with brain tumors following fatal crash arrest, friend says A friend of the Minnesota lawyer who was arrested last week after the SUV he was driving hit and killed a jogger told a local news outlet that he has since been diagnosed with brain tumors.
Gene therapy to fight a blood cancer succeeds in major study An experimental gene therapy that turns a patient's own blood cells into cancer killers worked in a major study, with more than one-third of very sick lymphoma patients showing no sign of disease six months after a single treatment, its maker said Tuesday.
Merck KGaA, Pfizer get priority review for bladder cancer drug German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek to widen the use of immunotherapy drug avelumab to include bladder cancer.
Merck drug prevents serious infection after marrow transplant: study An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a late state study, the company said.
Family honors son with $1.25M donation to help blood cancer patients enroll in clinical trials A Minnesota family’s recent $1.25 million donation to the Be The Match Foundation will go toward building a better network for patients and families desperately searching for potentially life-saving clinical trials.
6-year-old's snowboarding injury leads to inoperable brain tumor diagnosis For the family of 6-year-old Devin Suau, every day is a race against the clock.
Many US cancer patients struggle to afford life-saving medications As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with paying for prescription medications, according to a recent study.